Cargando…
Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no?
Excessive alcohol intake is an established risk factor for chronic liver disease. At the same time, moderate alcohol intake appears to reduce cardiovascular morbidity. Accordingly, recommendations for alcohol intake in patients with nonalcoholic fatty liver disease (NAFLD), who are at increased risk...
Autores principales: | Protopapas, Adonis A., Cholongitas, Evangelos, Chrysavgis, Lampros, Tziomalos, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276351/ https://www.ncbi.nlm.nih.gov/pubmed/34276185 http://dx.doi.org/10.20524/aog.2021.0641 |
Ejemplares similares
-
Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020) -
Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
por: Sofogianni, Areti, et al.
Publicado: (2020) -
Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease
por: Karakousis, Nikolaos D., et al.
Publicado: (2022) -
Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
por: Chrysavgis, Lampros, et al.
Publicado: (2022) -
Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
por: Makri, Evangelia, et al.
Publicado: (2016)